Skip to main content
. 2016 Aug 19;30(12):3997–4006. doi: 10.1096/fj.201600728R

Figure 6.

Figure 6.

NOX2 inhibitor blocks buildup of ROS in CMs and release of IL-1β. A, B) Cytosolic ROS (A) and nuclear/mitochondrial ROS (B) in absence or presence of NOX2 inhibitor in rat CMs exposed to C5a for 1 h at 37°C. C) Companion studies focused on IL-1β release from C5a-activated CMs in the presence or absence of NOX2 inhibitor. CMs exposed to C5a for 8 h. For each bar, n ≥ 4 samples. *P < 0.05.